skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article
Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Cell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077

Full text available

2
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
Material Type:
Article
Add to My Research

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice

Proceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (38) [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Sep 21, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2106845118 ;PMID: 34493582

Full text available

3
Rapid and automated design of two-component protein nanomaterials using ProteinMPNN
Material Type:
Article
Add to My Research

Rapid and automated design of two-component protein nanomaterials using ProteinMPNN

Proceedings of the National Academy of Sciences - PNAS, 2024-03, Vol.121 (13), p.e2314646121-e2314646121 [Peer Reviewed Journal]

Copyright © 2024 the Author(s). Published by PNAS. 2024 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2314646121 ;PMID: 38502697

Full text available

4
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Material Type:
Article
Add to My Research

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

Cell Reports, 2022-08, Vol.40 (9), p.111299-111299, Article 111299 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.111299 ;PMID: 35988541

Digital Resources/Online E-Resources

5
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article
Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

6
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
Material Type:
Article
Add to My Research

Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses

Immunity (Cambridge, Mass.), 2023-10, Vol.56 (10), p.2425 [Peer Reviewed Journal]

ISSN: 1097-4180 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2023.08.011

Digital Resources/Online E-Resources

7
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Material Type:
Article
Add to My Research

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

npj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518

Full text available

8
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article
Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

bioRxiv, 2021-03

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528

Digital Resources/Online E-Resources

9
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Material Type:
Article
Add to My Research

Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates

bioRxiv, 2021-02

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696

Digital Resources/Online E-Resources

10
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Material Type:
Article
Add to My Research

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

bioRxiv, 2022-02

2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2022.02.07.479468

Digital Resources/Online E-Resources

11
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design
Material Type:
Article
Add to My Research

Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design

bioRxiv, 2021-05

2021. This article is published under https://creativecommons.org/publicdomain/zero/1.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.05.15.444222

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (7)

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait